Increased expression of TGF-β1 but not of its receptors contributes to human obstructive nephropathy

Kidney International

Volumn 56, Issue 6, 1999, Pages 2137-2146

  Kaneto, Hiroyuki ^a   Ohtani, Haruo ^a   Fukuzaki, Atsushi ^a   Ishidoya, Shigeto ^a   Takeda, Atsushi ^a   Ogata, Yukihiko ^a   Nagura, Hiroshi ^a   Orikasa, Seiichi ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cytokine; Fibrosis; Hydronephrosis; Renal injury; Tubulointerstitial disease; Unilateral ureteral obstruction

Indexed keywords

COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 4; FIBRONECTIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; EXTRACELLULAR MATRIX; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; HYDRONEPHROSIS; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY FIBROSIS; KIDNEY INTERSTITIUM; MALE; OBSTRUCTIVE UROPATHY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; URETER OBSTRUCTION;

EID: 0033429120     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00790.x     Document Type: Article

References (33)

1. 1. Kaneto H, Morrissey J, Klahr S: Increased expression of TGF-β1 mRNA in the obstructed kidney of rats with unilateral ureteral ligation. Kidney Int 44:313-321, 1993
2. 2. Ishidoya S, Morrissey J, McCracken R, Klahr S: Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction. Kidney Int 47:1285-1294, 1995
3. 3. Diamond JR, Kees-Folts D, Ding G, Frye JE, Restrepo NC: Macrophages, monocyte chemoattractant peptide-1, and TGF-β1 in experimental hydronephrosis. Am J Physiol 266:F926-F933, 1994
4. 4. Sharma AK, Mauer SM, Kim Y, Michael AF: Interstitial fibrosis in obstructive nephropathy. Kidney Int 44:774-788, 1993
5. 5. Pimentel JL, Sundell CL, Wang S, Kopp JB, Montero A, Martinez-Maldonado M: Role of angiotensin II in the expression and regulation of transforming growth factor-β in obstructive nephropathy. Kidney Int 48:1233-1246, 1995
6. 6. Palmer LS, Maizels M, Kaplan WE, Firlit CF, Cheng EY: Urine levels of transforming growth factor-β1 in children with ureteropelvic junction obstruction. Urology 50:769-773, 1997
7. 7. Okadome T, Yamashita H, Franzen P, Moren A, Heldin CH, Miyazono K: Distinct roles of the intracellular domains of transforming growth factor-β type I and type II receptors in signal transduction. J Biol Chem 269:30753-30756, 1994
8. 8. Wrana JL, Attisano L, Wieser R, Ventura F, Massague J: Mechanism of activation of the TGF-β receptor. Nature 370:341-347, 1994
9. 9. Tamaki K, Okuda S, Ando T, Iwamoto T, Nakayama N, Fujishima M: TGF-β1 in glomerulosclerosis and interstitial fibrosis of adriamycin nephropathy. Kidney Int 45:525-536, 1994
10. 10. Sutaria PM, Ohebshalom M, McCaffrey TA, Vaughan ED Jr, Felsen D: Transforming growth factor-β receptor types I and II are expressed in renal tubules and are increased after chronic unilateral ureteral obstruction. Life Sci 62:1965-1972, 1998
11. 11. Moller JC, Skriver E, Olsen S, Maunsbach AB: Ultrastructural analysis of human proximal tubules and cortical interstitium in chronic renal disease (hydronephrosis). Virchows Arch 402:209-237, 1984
12. 12. Kaneto H, Morrissey J, MacCracken R, Reyes AA, Klahr S: Enalapril reduces collagen type IV synthesis and expansion of the interstitium in the obstructed kidney of the rat. Kidney Int 45:1637-1647, 1994
13. 13. Olofsson A, Miyazono K, Kanzaki T, Colosetti P, Engstrom U, Heldin CH: Transforming growth factor-β1, -β2, and -β3 secreted by a human glioblastoma cell line. Identification of small and different forms of large latent complexes. J Biol Chem 267:19482-19488, 1992
14. 14. Franzen P, Ten Duke P, Ichijo H, Yamashita H, Schulz P, Heldin CH, Miyazono K: Cloning of a TGF β type I receptor that forms a heteromeric complex with the TGF β type II receptor. Cell 75:681-692, 1993
15. 15. Taketazu F, Kato M, Gobl A, Ichijo H, ten Dijke P, Itoh J, Kyogoku M, Ronnelid J, Miyazono K, Heldin CH, Funa K: Enhanced expression of transforming growth factor-βs and transforming growth factor-β type II receptor in the synovial tissues of patients with rheumatoid arthritis. Lab Invest 70:620-630, 1994
16. 16. Derynck R, Jarrett JA, Chen EY, Eaton DH, Bell JR, Assoian RK, Roberts AB, Sporn MB, Goeddel DV: Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells. Nature 316:701-705, 1985
17. 17. Lin HY, Wang XF, Ng-Eaton E, Weinberg RA, Lodish HF: Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase. Cell 68:775-785, 1992
18. 18. Brinker JM, Gudas LJ, Loidl HR, Wang SY, Rosenbloom J, Kefalides NA, Myers JC: Restricted homology between human alpha 1 type IV and other procollagen chains. Proc Natl Acad Sci USA 82:3649-3653, 1985
19. 19. Kornblihtt AR, Vibe-Pedersen K, Baralle FE: Isolation and characterization of cDNA clones for human and bovine fibronectins. Proc Natl Acad Sci USA 80:3218-3222, 1983
20. 20. Ercolani L, Florence B, Denaro M, Alexander M: Isolation and complete sequence of a functional human glyceraldehyde-3-phosphate dehydrogenase gene. J Biol Chem 263:15335-15341, 1988
21. 21. Norton PA, Hynes RO: Alternative splicing of chicken fibronectin in embryos and in normal and transformed cells. Mol Cell Biol 7:4297-4307, 1987
22. 22. Blaza E, Borsi L, Allemanni G, Zardi L: Transforming growth factor β regulates the levels of different fibronectin isoforms in normal human cultured fibroblasts. FEBS Lett 228:42-44, 1988
23. 23. Borsi L, Castellani P, Risso AM, Leprini A, Zardi L: Transforming growth factor-β regulates the splicing pattern of fibronectin messenger RNA precursor. FEBS Lett 261:175-178, 1990
24. 24. Viedt C, Burger A, Hansh GM: Fibronectin synthesis in tubular epithelial cells: Up-regulation of the EDA splice variant by transforming growth factor β. Kidney Int 48:1810-1817, 1995
25. 25. Burger A, Wagner C, Viedt C, Reis B, Hug F, Hansch GM: Fibronectin synthesis by human tubular epithelial cells in culture: Effects of PDGF and TGF-β on synthesis and splicing. Kidney Int 54:407-415, 1998
26. 26. Kuncio GS, Neilson EG, Haverty T: Mechanisms of tubulointerstitial fibrosis. Kidney Int 39:550-556, 1991
27. 27. Niemir ZI, Stein H, Noronha IL, Kruger C, Andrassy K, Ritz E, Waldherr R: PDGF and TGF-β contribute to the natural course of human IgA glomerulonephritis. Kidney Int 48:1530-1541, 1995
28. 28. Yoshioka K, Takemura T, Murakami K, Okada M, Hino S, Miyamoto H, Maki S: Transforming growth factor-β protein and mRNA in glomeruli in normal and diseased human kidneys. Lab Invest 68:154-163, 1993
29. 29. Schreiner GF, Harris KPG, Purkerson ML, Klahr S: Immunological aspects of acute ureteral obstruction: Immune cell infiltrate in the kidney. Kidney Int 34:487-493, 1988
30. 30. Yamamoto T, Noble NA, Miller DE, Boder WA: Sustained expression of TGF-β1 underlies development of progressive kidney fibrosis. Kidney Int 45:916-927, 1994
31. 31. Munger JS, Harpel JG, Gleizes PE, Mazzieri R, Nunes I, Rifkin DB: Latent transforming growth factor-β: Structural features and mechanisms of activation. Kidney Int 51:1376-1382, 1997
32. 32. Wright EJ, McCaffrey TA, Robertson AP, Vaughan ED Jr, Felsen D: Chronic unilateral ureteral obstruction is associated with interstitial fibrosis and tubular expression of transforming growth factor-β. Lab Invest 74:528-537, 1996
33. 33. Horvath LZ, Friess H, Schilling M, Borisch B, Deflorin J, Gold LI, Korc M, Buchler MW: Altered expression of transforming growth factor-βs in chronic renal rejection. Kidney Int 50:489-498, 1996